Status:
COMPLETED
FC Patch Comparator Study
Lead Sponsor:
Bayer
Conditions:
Contraception
Eligibility:
FEMALE
18-35 years
Phase:
PHASE3
Brief Summary
The purpose of this study is to compare bleeding pattern and safety of contraceptive patch SH P00331F to a marketed comparator.
Detailed Description
The study has previously been posted by Schering AG, Germany. Schering AG, Germany has been renamed to Bayer Schering Pharma AG, Germany.Bayer Schering Pharma AG, Germany is the sponsor of the trial.
Eligibility Criteria
Inclusion
- Healthy female volunteer aged 18-35, smokers 18-30
Exclusion
- Contraindications for using hormonal contraceptives
Key Trial Info
Start Date :
November 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2006
Estimated Enrollment :
422 Patients enrolled
Trial Details
Trial ID
NCT00185354
Start Date
November 1 2004
End Date
April 1 2006
Last Update
December 31 2015
Active Locations (28)
Enter a location and click search to find clinical trials sorted by distance.
1
Wörgl, Tyrol, Austria, 6300
2
Bregenz, Austria, 6900
3
Graz, Austria, 8010
4
Vienna, Austria, 1030